Search


	Podcast:		Industry Focus
	Episode:		Healthcare: Johnson & Johnson Takes A Shot At Gilead Sciences
	Category:		Business
	Duration:		00:13:46
	Publish Date:		2015-05-20 20:09:58
	Description:		Johnson & Johnson has inked a licensing deal with Achillion Pharmaceuticals that could threaten Gilead Sciences market share in hepatitis C someday. Motley Fool's Michael Douglass and Todd Campbell dig into the details of this deal to see if Gilead Sciences investors should worry.
	Total Play:		0